Tirzepatide
Dual GIP and GLP-1 action for appetite and metabolic support.
Prescription only. Requires medical evaluation. Not everyone qualifies.
What it is
Tirzepatide acts on two receptors, GIP and GLP-1. That dual mechanism is why many patients report stronger appetite regulation than with a single-pathway medication.
How treatment works
Your clinician starts you at an introductory dose and titrates gradually based on your response and tolerance.
Who it's for
- Adults seeking weight management support
- Patients who plateaued on a single-pathway GLP-1
- People who prefer a once-weekly injection
How to get started
Four steps, no surprises. Tap any step to see exactly what happens.
Intake
Tell us about your health, goals, and history through a private online questionnaire. About 5 minutes.
Tirzepatide is prepared as a compounded medication. Compounded medications are not FDA-approved and are prepared by licensed U.S. compounding pharmacies to meet specific patient needs. They are not reviewed by the FDA for safety, effectiveness, or quality, and are not generic equivalents of brand-name medications. They are prepared pursuant to a valid prescription for an individual patient by our pharmacy partners:
- DiRx, 3540 NW 56th St, STE 204, Ft Lauderdale FL 33309
Also in GLP-1 Weight Management
The most widely studied GLP-1 for long-term weight management.
Best for: Adults working on sustained weight management
A daily GLP-1 option with a shorter half-life.
Best for: Patients sensitive to weekly dosing
Semaglutide paired with vitamin B12 for energy support.
Best for: Patients starting GLP-1 therapy who want added B12
Dual-pathway therapy with added vitamin B12.
Best for: Patients on dual-pathway therapy who want added B12
See if Tirzepatide is right for you
Start your private medical intake. The $75 clinician consultation fee is only charged if a clinician approves you for treatment.
Prescription only. Requires medical evaluation. Not everyone qualifies.